View Press Releases
-
CD Formulation Newly Launches Drug Packaging Services for the Pharmaceutical Industry
Packaging is another factor that decides the stability and integrity of drugs. Except for the role as an excipient producer and supplier, the US-based CRO company CD Formulation today announces that it newly launches a wide range of pharmaceutical packaging services, providing support throughout the whole process of packaging design, from material selection to chemical and surface analysis and to design selection.
May 4, 2022
-
AVIA Names Daniel Clark Senior Vice President, Center for Care Transformation; Will Drive Digital Care Transformation Initiatives for Health Systems
Seasoned Clinical and Digital Executive Joins Leading Digital Transformation Company to Meet Demand for Digitally Enabled Care Models
May 4, 2022
-
2bPrecise Named “Best Overall Genomics Company” in 2022 MedTech Breakthrough Awards Program
-
Kyruus ProviderMatchⓇ Wins MedTech Breakthrough Award for Best Patient Scheduling Solution for Third Year in Row
Annual Awards Program Recognizes Outstanding Health & Medical Technology Products and Companies
May 4, 2022
-
Egle Therapeutics appoints Pierre Legault as Chairman and Board Member
Egle Therapeutics SAS (Egle), an emerging biotechnology company dedicated to developing novel immunotherapies for oncology and autoimmune diseases, is pleased to announce Pierre Legault as Chairman and board member as of March 2022.
May 4, 2022
-
Paradigm4 launches REVEAL: Proteomics to transform protein bio-markers research!
Paradigm4 has today unveiled REVEAL: Proteomics, the newest use case specific app powered by the Paradigm4 FLASH high-performance bioinformatics platform.
May 3, 2022
-
Rousselot® Biomedical announces the launch of Quali-Pure HGP 2000
Rousselot®, Darling Ingredients’ health brand and the global leader of collagen-based solutions1, launches Quali-Pure™ HGP 2000, a new endotoxin-controlled, pharmaceutical-grade gelatin specifically designed for vaccines and wound healing applications. As the latest addition to Rousselot Biomedical’s rapidly expanding product offering, this new non-gelling hydrolyzed gelatin further extends the scope of biomedical applications covered by Rousselot products.
May 3, 2022
-
Watson-Marlow Fluid Technology Solutions and the National Institute for Bioprocessing Research and Training partner for biopharma training programme
Watson-Marlow Fluid Technology Solutions (WMFTS) today announces it has partnered with the National Institute of Bioprocessing Research and Training (NIBRT) to develop and deliver a combined in-person and online global biopharma training programme for employees.
May 2, 2022
-
X-Therma organ preservation technology granted FDA breakthrough device status
-
PubMed Research Workflows Made Easier with PubHive Navigator
New Google Chrome Browser extension simplifies research workflows for corporate life science teams that use PubMed and subscribe to PubHive’s cloud software platform
May 2, 2022
-
ADC Technology: A Premier Institution of Antibody-Drug Conjugates Development
ADC Technology releases a wide range of one-stop services related to ADC development such as antibody selection/modification, ADC payload and linker development, ADC conjugation, and ADC characterization and preclinical evaluation to help partners win the race of ADC research.
Apr 19, 2022
-
Benefits of Stable Isotope Labelling in Biochemistry Research
Stable isotope labeling is a powerful technique with promising applications.
Apr 28, 2022
-
PROTAC-based Methods as Traditional PROTAC Protein Degradation Technology Alternatives
Many emerging PROTAC-based technologies such as RNA-PROTACs and Photoswitchable PROTACs have expanded the scope of PROTAC development, providing more feasible potential strategies for the clinical treatment of related diseases.
Apr 28, 2022
-
BOC Sciences Announces Featured PROTAC Design Services to Meet New Drug Discovery Goals
BOC Sciences announced featured PROTAC design services to customers around the world to meet new drug discovery goals.
Apr 28, 2022
-
Chemical Synthesis of Peptide Drug with Solid-Phase Methodology
Peptide plays a key role in basic biochemical and physiological processes, and it is essential to many aspects of biomedical research, especially when the pharmaceutical industry continues to apply new drug candidates in the biological field. Therefore, rapid, efficient, and reliable methodology for the chemical synthesis of peptide drugs is of utmost interest in chemical biology research.
Apr 28, 2022
-
Total Peptide Library: More Flexible and Productive
Since the peptide library provides a powerful tool for drug development, protein-protein interactions, and other biochemical as well as pharmaceutical applications, the total peptide library becomes a productive tool as it enjoys higher stability because of the special structure of the peptide bond. Additionally, its construction cycle is relatively short compared with traditional peptide library construction technologies, accelerating the development of peptides drugs.
Apr 28, 2022
-
New programme celebrates ChargePoint Technology's role in COVID-19 vaccine rollout
-
New Release of Genedata Imagence Advances AI-powered HCS Image Analysis
Genedata Imagence 5.0 industrializes the analysis of imaging assays across R&D organizations with advanced data QC workflows and scalable, flexible deployment options.
Apr 27, 2022
-
New BHM® Anti-Viral Nasal Spray launches in Singapore
Birmingham Biotech Ltd, an innovator in diagnostic tests, protective nasal sprays and mobile medical facilities, today announces the Singapore launch of its latest technology, BHM® Anti-Viral Nasal Spray, an easy-to-use nasal device with a unique patented formulation, Norizite™, designed to help prevent infection from the inhalation of airborne viruses within the nasal passages. The product will be available in Singapore from 1st May.
Apr 27, 2022
-
AARDEX® Group adds etectRx to their MEMS® Adherence Hardware ecosystem
AARDEX® Group adds etectRx to their MEMS® Adherence Hardware ecosystem The partnership sees the integration of AARDEX’s adherence analytics software with etectRx’s ingestible adherence sensor Liege, Belgium (APRIL 28th, 2022) – Belgium-based AARDEX® Group, the leader in measuring and managing medication adherence in clinical trials today announced a strategic partnership with etectRx, Inc. This new collaboration combines etectRx’s ingestible event marker, the ID-Cap™ System, and AARDEX® Group’s MEMS® Adherence Software (MEMS AS®) to track medication-taking behaviors. Together, they provide a holistic, objective, and precise method to measure and manage adherence to solid form dose medications.
Apr 27, 2022